Biologics and biosimilar products are the fastest growing pharmaceutical products in the US, being 3 of the top 5 best selling pharmaceutical products in the US in 2018. As such
going power struggle between China and the US, press plays an important role in shaping narratives on both sides. However, media coverage in the IndoPacific is influenced by a number ... Pacific agendas. It adds to a…
thing that is the intelligence of human body cells, which I believe to tell us of any damage that tries to harm this body. The body that tells us when ... choose a specific type of eating or a specific fruit can tell us…
21st Century Nanotechnology Research and Development Act. Over this period, the US has supported Nanotechnology R&D and education with $29 billion in support. As part of the nano
biosimilars price competition and innovation act, 14 biosimilar agents have been approved by the US Food and Drug Administration but only 4 biosimilars have reached the US market. None have ... specific challenges to…
preparation and planning that goes into submitting Clinical Trial Applications (CTA) to Ex-US countries. Alkermes has performed CTA submissions to countries such as Italy, Spain, Germany, the UK, Ireland ... will allow…
sources of stigma directed towards PLHIV. Studies have addressed the construct of stigma in US health care settings, but mainly from the perspectives of PLHIV. We used grounded theory
US Food and Drug Administration (FDA) defines a biomarker as “a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure
resource use (HCRU) and costs borne by commercial payers for sarcoidosis patients in the US. Patients (aged 18-64 years) with a first diagnosis of sarcoidosis between ... higher overall total healthcare costs ($19,714…
US military healthcare is delivered via one integrated system, with the Army, Navy, and Air Force considered different subsystems. The Military Health System (MHS) as a whole has faced
solutions of these therapy approaches particularly when combined with functional (SPECT) and anatomical imaging (US) hybrids and combinations with MRI imaging
trials involving the European Organisation for Research and Treatment of Cancer (EORTC) and the US-based National Cancer Institute intergroup system. Through examples, it is shown that the lead group
passage of 2009 Biologics Price Competition and Innovation Act of 2009 (BPCI Act) in US established a regulatory pathway for the approval and marketing of biosimilars in US. FDA subsequently ... Futhermore, the recent…
Biosimilar Era has arrived in the US! The past few months have seen the first ever FDA approval of a biologic deemed biosimilar to a previously approved biologic, the first ... cases of the Federal Circuit addressing…
regulatory landscape for the development of biosimilars in the US and EU is dynamic as many of the guidances issued by European Medicines Agency (EMA) have undergone revisions ... clarity as to FDA expectations.The…
countries however have very stringent regulatory guidelines for both Dietary supplements and Pharmaceutical products. US Dietary supplement companies face significantcomplexities understanding the guidelines followed in…
concomitant injection drug use (IDU). Eligible subjects were HIV positive adults followed at a US military treatment facility during the calendar year 2005. Incidence rates are calculated per 100 person
proposed here a compilation of US tide gauges with more than 70 years of measurements. The average sea level rise was 2.19 mm/year in 1999, 2.14 mm/year ... projections.While the IPCCprojections suppose the sea levels…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.